Oncology
 |
|
13 october 2018 22:00:18 |
| Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth (Oncogene) |
|
Tweet |
| 98 viewsCategory: Oncology |
 The promise of ESCAT: a new system for evaluating cancer drug-target pairs (Nature Clinical Practice Oncology)Acetylation of AGO2 promotes cancer progression by increasing oncogenic miR-19b biogenesis (Oncogene) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
